Literature DB >> 22943242

A pure dermal sling for implant reconstruction after mastectomy in the generous breast.

P Sarmah1, N Abbott, R Bright-Thomas.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22943242      PMCID: PMC3954387          DOI: 10.1308/rcsann.2012.94.5.364

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.951


× No keyword cloud information.

BACKGROUND

Skin reducing mastectomy is a useful technique in immediate implant-based reconstruction. The implant is usually covered by muscle and a dermal flap. We describe a modification to this technique for generous breasts involving the creation of a pure dermal sling. Pre-operative marking for Wise pattern incisions

TECHNIQUE

A skin reducing mastectomy is performed via Wise pattern incisions, retaining an extensive inferior dermal sling of de-epithelialised tissue. A sizer is used to ensure the skin envelope meets the inframammary fold before an anatomical implant is placed on the pectoralis major. Complete coverage is achieved with the inferior dermal sling, which is sutured to the pectoralis superiorly. The superior skin can then be draped to the inframammary fold and sutured in the usual manner.

DISCUSSION

The benefits of a pure dermal sling include complete coverage of the implant and the preservation of an intact pectoralis major. This technique has been trialled successfully in two patients with generous ptotic breasts. Pure dermal sling After reconstruction using pure dermal sling Results at four-month follow-up appointment
  1 in total

1.  Skin-reducing mastectomy with immediate implant reconstruction as an indispensable tool in the provision of oncoplastic breast services.

Authors:  Amit Nair; Sahila Jaleel; Nick Abbott; Pauline Buxton; Pilar Matey
Journal:  Ann Surg Oncol       Date:  2010-09       Impact factor: 5.344

  1 in total
  1 in total

Review 1.  Breast conservation surgery & oncoplasty in India - Current scenario.

Authors:  Vani Parmar; Chaitanyanand B Koppiker; Santosh Dixit
Journal:  Indian J Med Res       Date:  2021-08       Impact factor: 5.274

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.